Selegiline in Parkinson's disease
- PMID: 8555790
- PMCID: PMC2551489
- DOI: 10.1136/bmj.311.7020.1583
Selegiline in Parkinson's disease
Comment in
-
Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients.BMJ. 1996 Mar 16;312(7032):702; author reply 704-5. doi: 10.1136/bmj.312.7032.702. BMJ. 1996. PMID: 8597745 Free PMC article. No abstract available.
-
Unexpected findings of study of selegiline have not been treated with caution its authors advised.BMJ. 1997 Aug 9;315(7104):370. BMJ. 1997. PMID: 9270472 Free PMC article. No abstract available.
Comment on
-
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.BMJ. 1995 Dec 16;311(7020):1602-7. doi: 10.1136/bmj.311.7020.1602. BMJ. 1995. PMID: 8555803 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical